stacking tirzepatide and retatrutide vs (2026) T1D Log - 85 Days:

Overall vitality and metabolic balance

no human study has demonstrated an anti-fibrotic effect of systemic GHK-Cu, and the reconciliation of more collagen with less fibrosis remains a mechanistic argument rather than a measured clinical outcome

A structured peptide protocol with tracking and good skincare habits supports steady results and safety

METHODS: The phase 3a, 68-week REDEFINE 1 trial randomized adults without diabetes with body mass index 30 kg/m 2 , or 27 kg/m 2 with 1 obesity-related complication, to once-weekly CagriSema 2.4 mg/2.4 mg, semaglutide 2.4 mg, cagrilintide 2.4 mg, or placebo, plus lifestyle intervention